ABL’s President and CEO, Dr. Thomas VanCott, will attend the 11th Annual Biologics Forum in Tokyo, Japan on January 24, 2014. Dr. VanCott has been invited to speak at the conference on advances made in HIV vaccine research through projects performed at ABL.

If you would like additional information, please contact us.